According to the "Global Eye Health Invited Major Report", common eye diseases in China include refractive errors, conjunctivitis, dry eye syndrome, cataracts, blepharitis, retinal disorders, glaucoma, and uveitis. In terms of the number of patients, the number of patients with eye diseases in China is huge and far exceeds that of the United States. There is a large group of eye disease patients who have not received sufficient treatment, and there is a significant gap in the demand for eye disease diagnosis and treatment. According to data from the National Health Commission, in 2020, there were over 700 million myopia patients in China, accounting for nearly 50% of the country's population. The number of cataract patients exceeded 200 million. In addition, there are also large groups of patients with dry eye syndrome, glaucoma and other eye diseases.
In 2020, the number of myopia, dry eye syndrome, and cataract patients in China were 630 million, 250 million, and 140 million, respectively, totaling up to 1.02 billion people. The trend of acceleration in recent years is becoming increasingly evident. The trend of myopia becoming more common at a younger age and reaching a higher degree is severe. According to Frost & Sullivan, in 2020, there were already 173 million myopia patients under the age of 20 in China, and the average myopia rate among teenagers had also increased to 52.7%, with a myopia rate of 80.50% among high school students. The number of dry eye syndrome patients is continuously increasing and becoming younger, while the aging process is accelerating, resulting in a significant increase in the number of cataract patients.
In recent years, the problem of myopia among Chinese teenagers has gradually worsened. Supply-side prevention and control measures are constantly updated, and visual care service providers are rapidly expanding and improving their accessibility. Visual care products mainly include corneal contact lenses, frame glasses, and related care products. According to CICC's estimate, the market size of myopia prevention and control in China may reach approximately RMB 210 billion by 2030, with a ten-year compound growth rate of approximately 13.7%. Another report predicts that the market size of China's ophthalmic medical services is expected to maintain a growth rate of 16% in the next five years, reaching RMB 252.15 billion by 2025.
According to the "Global Eye Health Invited Major Report", common eye diseases in China include refractive errors, conjunctivitis, dry eye syndrome, cataracts, blepharitis, retinal disorders, glaucoma, and uveitis. In terms of the number of patients, the number of patients with eye diseases in China is huge and far exceeds that of the United States. There is a large group of eye disease patients who have not received sufficient treatment, and there is a significant gap in the demand for eye disease diagnosis and treatment. According to data from the National Health Commission, in 2020, there were over 700 million myopia patients in China, accounting for nearly 50% of the country's population. The number of cataract patients exceeded 200 million. In addition, there are also large groups of patients with dry eye syndrome, glaucoma and other eye diseases.
In 2020, the number of myopia, dry eye syndrome, and cataract patients in China were 630 million, 250 million, and 140 million, respectively, totaling up to 1.02 billion people. The trend of acceleration in recent years is becoming increasingly evident. The trend of myopia becoming more common at a younger age and reaching a higher degree is severe. According to Frost & Sullivan, in 2020, there were already 173 million myopia patients under the age of 20 in China, and the average myopia rate among teenagers had also increased to 52.7%, with a myopia rate of 80.50% among high school students. The number of dry eye syndrome patients is continuously increasing and becoming younger, while the aging process is accelerating, resulting in a significant increase in the number of cataract patients.
In recent years, the problem of myopia among Chinese teenagers has gradually worsened. Supply-side prevention and control measures are constantly updated, and visual care service providers are rapidly expanding and improving their accessibility. Visual care products mainly include corneal contact lenses, frame glasses, and related care products. According to CICC's estimate, the market size of myopia prevention and control in China may reach approximately RMB 210 billion by 2030, with a ten-year compound growth rate of approximately 13.7%. Another report predicts that the market size of China's ophthalmic medical services is expected to maintain a growth rate of 16% in the next five years, reaching RMB 252.15 billion by 2025.
【Scan and follow us】